Search results for "maze"

showing 10 items of 199 documents

Pathology-selective antiepileptic effects in the focal freeze-lesion rat model of malformation of cortical development

2021

Malformations of cortical development (MCD) represent a group of rare diseases with severe clinical presentation as epileptic and pharmacoresistant encephalopathies. Morphological studies in tissue from MCD patients have revealed reduced GABAergic efficacy and increased intracellular chloride concentration in neuronal cells as important pathophysiological mechanisms in MCD. Also, in various animal models, alterations of GABAergic inhibition have been postulated as a predominant factor contributing to perilesional hyperexcitability. Along with this line, the NKCC1 inhibitor bumetanide has been postulated as a potential drug for treatment of epilepsy, mediating its antiepileptic effect by red…

Male0301 basic medicinePathologymedicine.medical_specialtyZonisamideInhibitory postsynaptic potentialCryosurgeryLesion03 medical and health sciencesEpilepsyOrgan Culture Techniques0302 clinical medicineSodium Potassium Chloride Symporter InhibitorsDevelopmental NeuroscienceSeizuresmedicineAnimals4-AminopyridineRats WistarBumetanideCerebral Cortexbusiness.industryCarbamazepinemedicine.diseaseRatsMicrogyrusMalformations of Cortical Development030104 developmental biologyNeurologyGABAergicAnticonvulsantsmedicine.symptombusiness030217 neurology & neurosurgeryBumetanidemedicine.drugExperimental Neurology
researchProduct

Real-life use of elbasvir/grazoprevir in adults and elderly patients: a prospective evaluation of comedications used in the PITER cohort.

2021

Background In patients treated for HCV infection, potential drug–drug interactions (DDIs) can occur among direct-acting antiviral drugs (DAAs) and comedications used. The real-life effectiveness and safety of elbasvir/grazoprevir (ELB/GZR) among co-medicated HCV patients was evaluated. Methods We prospectively evaluated consecutive patients from 15 clinical centres participating in PITER who were treated with ELB/GZR and had been followed for at least 12 weeks after treatment. Data were prospectively collected on the use of comedications (including discontinuation, dose modification and addition of drugs) and potential DDIs with DAAs. Results Of the 356 patients with at least 12-week post-t…

Male030312 virologycombination therapytreatment experienced patientsDrug Combinationchronic hepatitis C drug drug interactions virus genotype 1 treatment experienced patients pump inhibitor use combination therapy treatment naive liver fibrosisgrazoprevir elbasvir80 and overAge FactorPharmacology (medical)Drug InteractionsProspective StudiesChronicProspective cohort studyliver fibrosisAged 80 and over0303 health sciencesAge FactorsImidazolesMiddle AgedHepatitis CDrug CombinationsInfectious DiseasesTreatment OutcomeDrug InteractionGrazoprevirCohortdrug drug interactionsFemalepump inhibitor useHumanmedicine.drugmedicine.medical_specialtyElbasvirQuinoxalinetreatment naiveelbasvirAntiviral AgentsNO03 medical and health sciencesInternal medicineQuinoxalinesmedicinechronic hepatitis CElbasvir GrazoprevirHumansImidazoleAgedBenzofuransAntiviral AgentPharmacology...business.industrygrazoprevirCarbamazepineHepatitis C Chronicmedicine.diseaseComorbidityDiscontinuationBenzofuranAge Factors; Aged; Aged 80 and over; Antiviral Agents; Benzofurans; Drug Combinations; Drug Interactions; Female; Hepatitis C Chronic; Humans; Imidazoles; Male; Middle Aged; Prospective Studies; Quinoxalines; Treatment Outcomebusinessvirus genotype 1Antiviral therapy
researchProduct

Effects of acute administration of bupropion on behavior in the elevated plus-maze test by NMRI mice

2004

Bupropion attenuates some symptoms of nicotine abstinence, although its effects on anxiety are unclear. The present study investigates acute effects of bupropion (5, 10, 20 and 40 mg/kg) on anxiety as expressed in the elevated plus-maze test in male NMRI mice. Given the influence of locomotion in this test, effects of bupropion were also evaluated in an actimeter. Spontaneous motor activity remained significantly increased in mice treated with 10, 20 and 40 mg/kg of bupropion during the 60 min recorded. Results from the elevated plus-maze showed that 20 mg/kg increased total arm entries and 40 mg/kg increased total and open arm entries. Although the increase in the number of visits to the o…

MaleAcute effectsElevated plus mazemedicine.drug_classmedia_common.quotation_subjectAnxietyMotor ActivityPharmacologyAnxiolyticNicotineMicemedicineAnimalsBupropionBiological Psychiatrymedia_commonPharmacologyBupropionBehavior AnimalDose-Response Relationship DrugAbstinenceNmri miceAntidepressive Agents Second-GenerationAnxietymedicine.symptomPsychologymedicine.drugProgress in Neuro-Psychopharmacology and Biological Psychiatry
researchProduct

Age differences in the role of the cannabinoid type 1 receptor on glutamatergic neurons in habituation and spatial memory acquisition

2015

Abstract Aims Aging is typically linked with a decline in memory performance and alterations in neural integrity. In pathological aging such as Alzheimer's disease, these effects are aggravated. Studies using cannabinoid CB1 receptor-deficient mice have shown a role of the endocannabinoid system in memory processing and neuroprotection. As the CB1 receptor is expressed in various neuronal populations, in this study, we aimed at investigating the consequences of CB1 receptor gene inactivation in cortical glutamatergic neurons in mice (Glu-CB1-KO) in regard to age-related alterations in spatial memory performance. Main methods Juvenile (5.5–7.5 weeks), adult (5.5–7 months), and old (11.5–14 m…

MaleAgingCannabinoid receptormedicine.medical_treatmentMorris water navigation taskBiologyGeneral Biochemistry Genetics and Molecular BiologyMiceGlutamatergicGlutamatesReceptor Cannabinoid CB1medicineAnimalsMemory impairmentGeneral Pharmacology Toxicology and PharmaceuticsHabituationHabituation PsychophysiologicMaze LearningSpatial MemoryMice KnockoutNeuronsThigmotaxisLearning DisabilitiesGeneral MedicineEndocannabinoid systemMice Inbred C57BLnervous systemlipids (amino acids peptides and proteins)CannabinoidNeurosciencePsychomotor Performancepsychological phenomena and processesLife Sciences
researchProduct

Effects of Early Training and Nicotine Treatment on the Performance of Male NMRI Mice in the Water Maze

2004

This research aimed to evaluate the effect of nicotine treatment and prior training on a spatial learning task in differently aged NMRI male mice. In a longitudinal study, mice were randomly assigned to one of 14 experimental groups receiving different combinations of chronically injected nicotine (0.35 mg/kg) administered for 10 days (5 days before and during 5 days acquisition of task) or control treatments and training in the water maze at different ages. The mice displayed shorter escape latencies when evaluated at 6 and 10 months than when tested in this task at 2 months for the first time, demonstrating that early training preserves performance in the water maze up to 8 months after t…

MaleAgingNicotineMaze learningMale miceWater mazeArticlelcsh:RC321-571Developmental psychologyNicotineMiceMemorymedicineAnimalsLongitudinal StudiesNicotinic AgonistsMaze Learninglcsh:Neurosciences. Biological psychiatry. NeuropsychiatryNicotinic agonistNeurologyNmri miceReference memoryAnesthesiaSpatial learningNeurology (clinical)Psychologymedicine.drugNeural Plasticity
researchProduct

The novelty-seeking phenotype modulates the long-lasting effects of intermittent ethanol administration during adolescence.

2013

The aim of the present study was to investigate if a novelty-seeking phenotype mediates the long-lasting consequences of intermittent EtOH intoxication during adolescence. The hole board test was employed to classify adolescent mice as High- or Low-Novelty Seekers. Subsequently, animals were administered ethanol (1.25 or 2.5 g/kg) on two consecutive days at 48-h intervals over a 14-day period. Anxiety levels - measured using the elevated plus maze- spontaneous motor activity and social interaction test were studied 3 weeks later. A different set of mice underwent the same procedure, but received only the 2.5 g/kg dose of ethanol. Three weeks later, in order to induce CPP, the same animals w…

MaleAginglcsh:MedicinePoison controlSocial SciencesAnxietyToxicologychemistry.chemical_compoundMiceBehavioral NeuroscienceCocaineMedicine and Health SciencesPsychologyPublic and Occupational Healthlcsh:ScienceHole-board testMultidisciplinaryAlcohol ConsumptionBehavior AnimalMDMAPhenotypeBehavioral PharmacologyAnxietymedicine.symptomBehavioral and Social Aspects of HealthReinforcement Psychologymedicine.drugResearch Articlemedicine.medical_specialtyElevated plus mazeAdolescentmedicine.drug_classN-Methyl-34-methylenedioxyamphetamineBiologyAnxiolyticInternal medicineMental Health and PsychiatrymedicineAnimalsHumansMaze LearningNutritionPharmacologyBehaviorEthanolEthanollcsh:RNovelty seekingBiology and Life SciencesDietEndocrinologychemistryExploratory Behaviorlcsh:QClinical MedicineNeurosciencePloS one
researchProduct

Bupropion induced changes in exploratory and anxiety-like behaviour in NMRI male mice depends on the age

2013

The aim of this study was to assess the effects of the antidepressant bupropion on anxiety and novelty-seeking in adolescent mice of different ages and adults. Behavioural differences between early adolescent, late adolescent and adult NMRI mice were measured both in the elevated plus-maze and the hole-board tasks following acute administration of bupropion (5, 10, 15, 20 mg/kg) or saline. In the plus maze test, early and late adolescent mice treated with bupropion (10, 15 mg/kg, respectively) had lower percentages of entries in the open-arms compared to their vehicle controls. Adult mice treated with bupropion did not differ from their vehicle controls. These results suggest that the effec…

MaleAgingmedicine.medical_specialtyElevated plus mazeHole-boardDEFICIT HYPERACTIVITY DISORDERmedicine.medical_treatmentAnxietySUBSTANCE USE DISORDERSINDIVIDUAL-DIFFERENCESHOLE-BOARD TESTMiceBehavioral NeuroscienceADULT RATSInternal medicinemedicineAnimalsSOCIAL-BEHAVIORMaze LearningPsychiatryBupropionBupropionHole-board testDose-Response Relationship DrugLOCOMOTOR-ACTIVITYNovelty seekingELEVATED PLUS-MAZEGeneral MedicineSMOKING-CESSATIONNICOTINE DEPENDENCEAdolescenceEndocrinologyNovelty-seekingAnxiogenicExploratory BehaviorAntidepressive Agents Second-GenerationSmoking cessationAntidepressantAnxietyAnimal Science and Zoologymedicine.symptomPsychologypsychological phenomena and processesmedicine.drugBehavioural Processes
researchProduct

Increased Anxiety-Like Behavior and Ethanol Self-Administration in Dependent Rats: Reversal via Corticotropin-Releasing Factor-2 Receptor Activation

2004

Background: Corticotropin-releasing factor (CRF) has been hypothesized to be one of the main regulators of the stress response observed during alcohol withdrawal. The CRF receptor subtypes seem to have a differential role in the regulation of stress-related behavior. Given the behavioral characterization of these receptors, the objective of the following experiments was to characterize the role of CRF2 receptors in the interaction between alcohol and stress by examining the effects of CRF2 receptor activation in the behavioral stress response and ethanol self-administration during early ethanol withdrawal in dependent rats. Methods: Male Wistar rats were made dependent on ethanol via chroni…

MaleAgonistElevated plus mazemedicine.medical_specialtyLiquid dietCorticotropin-Releasing Hormonemedicine.drug_classMedicine (miscellaneous)Self AdministrationAnxietyToxicologyReceptors Corticotropin-Releasing HormoneCorticotropin-releasing hormoneInternal medicinemedicineAnimalsRats WistarReceptorUrocortinsUrocortinDose-Response Relationship DrugEthanolChemistryRatsSubstance Withdrawal SyndromeAlcoholismPsychiatry and Mental healthDose–response relationshipEndocrinologyExploratory BehaviorSelf-administrationAlcoholism: Clinical and Experimental Research
researchProduct

Fasted-state simulated intestinal fluid "FaSSIF-C", a cholesterol containing intestinal model medium for in vitro drug delivery development.

2015

A set of biorelevant media "fasted-state simulated intestinal fluid with cholesterol (FaSSIF-C)" for the in vitro study of intestinal drug dissolution in the duodenum was developed. These contain cholesterol at the same levels as in human bile: the cholesterol content of FaSSIF-7C is equivalent to healthy female, FaSSIF-10C to healthy male persons, and FaSSIF-13C to several disease cases that lead to gallstones. The fluids were studied in three aspects: biocompatibility, intestinal nanostructure, and solubilizing power of hydrophobic drugs of the BCS class II. The biocompatibility study showed no toxic effects in a Caco-2 cell system. The drug-solubilizing capacity toward Fenofibrate, Danaz…

MaleBiocompatibilityPharmaceutical ScienceMicelleHigh cholesterolGriseofulvinchemistry.chemical_compoundDrug Delivery SystemsFenofibratemedicineHumansDissolution testingIntestinal MucosaParticle SizeFenofibrateChromatographyCholesterolDanazolFastingModels TheoreticalGriseofulvinmedicine.diseaseBody FluidsCarbamazepineCholesterolchemistryIntestinal AbsorptionSolubilityDrug deliveryFemaleCaco-2 Cellsmedicine.drugJournal of pharmaceutical sciences
researchProduct

Oral lichenoid drug reaction by lithium in a patient with bipolar disorder

2005

Bipolar disorder (BD) is a psychiatric disease characterized by recurrent and alternated episodes of depression and mania. For the treatment of BD, anticonvulsants drugs as lithium, carbamazepine and oxcarbazepine can be used. These drugs can be associated with potential adverse effects: weight gain, tremors, thyroid abnormalities, and cognitive, gastrointestinal, cardiac or dermatological problems. We describe a case of BD with oral lichenoid drug reaction probably because of the mood stabilizers.

MaleCancer Researchmedicine.medical_specialtyBipolar DisorderLichenoid EruptionsLithium (medication)antipsychotics bipolar disorders drug reaction lichenoid lesions lithium therapyPathology and Forensic Medicinechemistry.chemical_compoundLithium CarbonateAntimanic Agentsmental disordersmedicineHumansBipolar disorderOxcarbazepineAdverse effectbusiness.industryLithium carbonateCarbamazepineMiddle Agedmedicine.diseaseDermatologySurgeryOtorhinolaryngologychemistryLichenoid eruptionPeriodonticsOral Surgerymedicine.symptomMouth DiseasesbusinessManiamedicine.drugJournal of Oral Pathology and Medicine
researchProduct